Clinical efficacy of atomolan in treatment of the patients with virus hepatitis

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2003, Vol. 8 ›› Issue (3): 351-353.

Previous Articles Next Articles

Clinical efficacy of atomolan in treatment of the patients with virus hepatitis

LUAN Ling¹, ZHANG Jing-Liang

Department of Infectious Disease, ¹Department of Pharmacy, The Fourth People's Hospital of Zibo, Zibo 255067, Shandong

Received:2002-10-30 Revised:2003-01-03 Online:2003-06-26 Published:2020-11-25

Abstract

Abstract: AIM: To observe clinical efficacy of atomolan in treatment of the patients with virus hepatitis. METHODS: 96 patients were randomly divided into 2 groups.46 patients as a control group were given conventional treatment.50 patients as a treatment group were administered atomolan 1.8 g·d ^-1 iv gtt for 1mon on base of conventional treatment. RESULTS: After the therapy, the clinical symptoms and liver function in the treatment group was improved than that in the control group.The general effect was 90.0 % and 54.3 % in 2 groups.Side effects had not been found. CONCLUSION: Atomolan is an effective agent in treatment of the patients with virus hepatitis.

Key words: phaemacodynamics, atomolan, virus hepatitis, side effects

CLC Number:

LUAN Ling, ZHANG Jing-Liang. Clinical efficacy of atomolan in treatment of the patients with virus hepatitis[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(3): 351-353.

[1]	WANG Zhi, ZHOU Xin, HE Xueru, FU Yuhao, XUN Xuejiao, LI Ying, DONG Zhanjun. Clinical research progress of palbociclib in treatment of breast cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 205-213.
[2]	SHENG Haoyu, QUAN Bin, LIANG Manman, WU Qiongle, YANG Jianghua. Side effects of lopinavir/ritonavir for COVID-19 [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(11): 1283-1287.
[3]	DU Xiang-hui, JI Yong-lin, WANG Xiao-jia. The influence of the drug on the fetus of diagnosis and treatment of breast cancer during pregnancy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(2): 206-213.
[4]	WEI Chuan-mei, LIU Hui, GUO Rui-chen, FU Chong-ming. RelationshiPof plasma risperidone concentration and the efficacy in treatment of first-episode schizophrenia after a middle or low dosage risperidone adminstration [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(11): 1313-1316.
[5]	WU Nan, WANG Ai-Ping. Immunotoxicology applied in new drug safety assessment [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(8): 855-858.
[6]	ZHOU Jie, LEI Zhen-Wu, XU Xiao-Wen, LV Jie-Qiang, SUN Jing,WANG Fang. Evaluation of efficacy and safety of depot medroxyprogesterone acetate in treatment of patients with recurrent pain of postoperative endometriosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(8): 889-892.
[7]	ZHANG Jing-Liang, JIA Chuan-Chun, LUAN Ling. Comparison of the efficacy between stronger Neo-Minophagen C(SNMC) and caryophyllin in treatment of patients with chronic hepatitis B [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(2): 207-209.
[8]	ZHANG Jing-Ling, GU Jing-Jing, WANG Tian-Dong. Clinical observation of interferon α-1b combined with oxymatrine in the treatment of chronic hepatitis B [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(4): 344-346.

Clinical efficacy of atomolan in treatment of the patients with virus hepatitis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 8

Recommended Articles

Metrics

Comments